cbdMD, Inc. (NYSEAMERICAN:YCBD) Short Interest Down 49.7% in March

cbdMD, Inc. (NYSEAMERICAN:YCBD) saw a significant decrease in short interest in the month of March. As of March 13th, there was short interest totaling 554,205 shares, a decrease of 49.7% from the February 26th total of 1,102,343 shares. Based on an average daily trading volume, of 516,984 shares, the days-to-cover ratio is presently 1.1 days. Approximately 5.6% of the company’s shares are short sold.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC acquired a new stake in cbdMD, Inc. (NYSEAMERICAN:YCBD) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned 0.49% of cbdMD at the end of the most recent reporting period. Institutional investors and hedge funds own 7.18% of the company’s stock.

cbdMD Stock Performance

Shares of NYSEAMERICAN:YCBD traded down $0.05 during mid-day trading on Thursday, hitting $0.76. The company had a trading volume of 817,716 shares, compared to its average volume of 469,181. cbdMD has a one year low of $0.47 and a one year high of $3.36. The firm has a fifty day moving average price of $0.81 and a 200 day moving average price of $0.92.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.